144 related articles for article (PubMed ID: 8570730)
61. Topical application of a first porphycene dye for photodynamic therapy--penetration studies in human perilesional skin and basal cell carcinoma.
Karrer S; Abels C; Szeimies RM; Bäumler W; Dellian M; Hohenleutner U; Goetz AE; Landthaler M
Arch Dermatol Res; 1997 Feb; 289(3):132-7. PubMed ID: 9128760
[TBL] [Abstract][Full Text] [Related]
62. Photodynamic diagnosis and therapy in dermatology.
Fritsch C; Lang K; Neuse W; Ruzicka T; Lehmann P
Skin Pharmacol Appl Skin Physiol; 1998; 11(6):358-73. PubMed ID: 10343206
[TBL] [Abstract][Full Text] [Related]
63. Treatment of skin cancer and pre-cancer using topical ALA-PDT--a single hospital experience.
Wang XL; Wang HW; Guo MX; Xu SZ
Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):127-33. PubMed ID: 19356643
[TBL] [Abstract][Full Text] [Related]
64. Evaluation of the penetration of 5-aminolevulinic acid through basal cell carcinoma: a pilot study.
Ahmadi S; McCarron PA; Donnelly RF; Woolfson AD; McKenna K
Exp Dermatol; 2004 Jul; 13(7):445-51. PubMed ID: 15217365
[TBL] [Abstract][Full Text] [Related]
65. The temperature dependence of porphyrin production in Propionibacterium acnes after incubation with 5-aminolevulinic acid (ALA) and its methyl ester (m-ALA).
Ramstad S; Le Anh-Vu N; Johnsson A
Photochem Photobiol Sci; 2006 Jan; 5(1):66-72. PubMed ID: 16395429
[TBL] [Abstract][Full Text] [Related]
66. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
67. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin.
Henderson BW; Vaughan L; Bellnier DA; van Leengoed H; Johnson PG; Oseroff AR
Photochem Photobiol; 1995 Oct; 62(4):780-9. PubMed ID: 7480155
[TBL] [Abstract][Full Text] [Related]
68. Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma.
Casas A; Fukuda H; Meiss R; Batlle AM
Cancer Lett; 1999 Jul; 141(1-2):29-38. PubMed ID: 10454240
[TBL] [Abstract][Full Text] [Related]
69. Novel patch-based systems for the localised delivery of ALA-esters.
Morrow DI; McCarron PA; Woolfson AD; Juzenas P; Juzeniene A; Iani V; Moan J; Donnelly RF
J Photochem Photobiol B; 2010 Oct; 101(1):59-69. PubMed ID: 20634088
[TBL] [Abstract][Full Text] [Related]
70. Photodynamic therapy using topically applied hypericin: comparative effect with methyl-aminolevulinic acid on UV induced skin tumours.
Boiy A; Roelandts R; de Witte PA
J Photochem Photobiol B; 2011 Feb; 102(2):123-31. PubMed ID: 21035351
[TBL] [Abstract][Full Text] [Related]
71. Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application.
Orenstein A; Kostenich G; Tsur H; Kogan L; Malik Z
Cancer Lett; 1995 Jul; 93(2):227-32. PubMed ID: 7621433
[TBL] [Abstract][Full Text] [Related]
72. Recurrence rate of basal cell carcinoma after topical aminolevulinic acid-based photodynamic therapy.
Naidenov N; Dencheva R; Tsankov N
Acta Dermatovenerol Croat; 2004; 12(3):157-61. PubMed ID: 15369639
[TBL] [Abstract][Full Text] [Related]
73. A photodynamic therapy combined with topical 5-aminolevulinic acid and systemic hematoporphyrin derivative is more efficient but less phototoxic for cancer.
Wang Y; Lin Y; Zhang HG; Zhu J
J Cancer Res Clin Oncol; 2016 Apr; 142(4):813-21. PubMed ID: 26581214
[TBL] [Abstract][Full Text] [Related]
74. Sequential treatment of giant basal cell carcinomas.
Madan V; West CA; Murphy JV; Lear JT
J Plast Reconstr Aesthet Surg; 2009 Oct; 62(10):e368-72. PubMed ID: 18572004
[TBL] [Abstract][Full Text] [Related]
75. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.
de Haas ER; Kruijt B; Sterenborg HJ; Martino Neumann HA; Robinson DJ
J Invest Dermatol; 2006 Dec; 126(12):2679-86. PubMed ID: 16841035
[TBL] [Abstract][Full Text] [Related]
76. 5-Aminolevulinic acid induced endogenous porphyrin fluorescence in 9L and C6 brain tumours and in the normal rat brain.
Hebeda KM; Saarnak AE; Olivo M; Sterenborg HJ; Wolbers JG
Acta Neurochir (Wien); 1998; 140(5):503-12; discussion 512-3. PubMed ID: 9728253
[TBL] [Abstract][Full Text] [Related]
77. Stimulation of Friend erythroleukemic cell cytodifferentiation by 5-amino levulinic acid; porphyrins, cell size, segregation of sialoglycoproteins, and nuclear translocation.
Malik Z; Lugaci H; Hanania J
Exp Hematol; 1988 Jun; 16(5):330-5. PubMed ID: 3163553
[TBL] [Abstract][Full Text] [Related]
78. Microscopic distribution of protoporphyrin (PpIX) fluorescence in superficial basal cell carcinoma during light-fractionated aminolaevulinic acid photodynamic therapy.
de Haas ER; de Bruijn HS; Sterenborg HJ; Neumann HA; Robinson DJ
Acta Derm Venereol; 2008; 88(6):547-54. PubMed ID: 19002337
[TBL] [Abstract][Full Text] [Related]
79. Photodynamic therapy with topical methyl aminolaevulinate for 'difficult-to-treat' basal cell carcinoma.
Vinciullo C; Elliott T; Francis D; Gebauer K; Spelman L; Nguyen R; Weightman W; Sheridan A; Reid C; Czarnecki D; Murrell D
Br J Dermatol; 2005 Apr; 152(4):765-72. PubMed ID: 15840111
[TBL] [Abstract][Full Text] [Related]
80. Topical Application of 5-Aminolevulinic Acid Is Sufficient for Photodynamic Therapy on Vocal Folds.
Zhang C; Gong T; Wang J; Chou A; Jiang JJ
Laryngoscope; 2019 Feb; 129(2):E80-E86. PubMed ID: 30408178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
